Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $764,758 | $0 | $785,844 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $1,078,321 | $290,922 | $0 | $1,077,326 |
| Operating Cash Flow | $1,078,321 | $1,055,680 | $0 | $1,863,169 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$955,311 | -$1,118,595 | -$1,383,241 | -$933,593 |
| Net Acquisitions | $171,736 | $1,000 | -$222,893 | $46,449 |
| Inv. Purchases | -$470,009 | -$74,572 | $85,677 | -$293,680 |
| Inv. Sales/Matur. | $592,319 | $1,168,218 | $144,973 | $1,078,538 |
| Other Inv. Act. | -$13,381 | -$161,143 | $201,873 | $312,522 |
| Investing Cash Flow | -$674,646 | -$185,091 | -$1,173,611 | $210,236 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $94,232 | -$79,044 | $471,831 | -$207,318 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$295,897 | -$301,819 | -$359,924 | -$1,034,872 |
| Other Fin. Act. | -$624,908 | -$252,764 | -$612,203 | -$419,390 |
| Financing Cash Flow | -$826,573 | -$633,627 | -$500,297 | -$1,661,580 |
| Forex Effect | $850 | $8,912 | $97,625 | -$86,767 |
| Net Chg. in Cash | -$422,048 | $245,874 | -$85,939 | -$389,751 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,637,323 | $9,391,450 | $9,477,388 | $9,867,140 |
| End Cash | $9,215,276 | $9,637,323 | $9,391,450 | $9,477,388 |
| Free Cash Flow | $123,009 | -$62,916 | $107,103 | $146,041 |